OptiBiotix home page

Shareholder Information

 

Shares In Issue

As at 18 August 2025, the number of shares in issue was 103,300,304.

Significant Shareholders

As at 18 August 2025, significant shareholders that hold more than 3% of the share capital of OptiBiotix Health Plc, and shareholdings of any other directors are detailed below:

  Number Ordinary Shares %
Stephen O'Hara (Director) 10,212,986 9.89
Finance Yorkshire Seedcorn Fund (FYSCF) 4,713,314 4.56
Alumni Capital  (USA) 3,200,000 3.10

Stephen O'Hara holds 6,099,135 shares under Option

Directors' Shareholders

  Number Ordinary Shares %
Stephen O'Hara (Director) 10,212,986 9.89
Neil Davidson (Director) 503,000 0.49
Sean Christie (Director) 150,000 0.15

Shares not in Public hands

In the terms of the AIM Rules and insofar as it is aware, at 18 August 2025, 23.2% of the Company's AIM securities was not in public hands.

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of OptiBiotix Health Plc's AIM securities.

Other exchanges and trading platforms

OptiBiotix Health Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

Date Name
07 August 2025 Results of the votes for the Annual General Meeting held on 06 August 2025
   
02 July 2025 Notice of Annual General Meeting held on 06 August 2025
  Proxy for Annual General Meeting held on 06 August 2025
   
08 August 2024 Results of the Proxy votes for the AGM held on 08 August 2024
   
26 July 2023 Results of the Proxy votes for the AGM held on 26 July 2023
   
28 June 2023 Notice of Annual General Meeting held on 26 July 2023
  Proxy for Annual General Meeting held on 26 July 2023
   
26 July 2022 Results of the Proxy votes for the AGM held on 26 July 2022
   
28 June 2022 Notice of Annual General Meeting held on 26 July 2022
   
09 July 2021 Shareholders Q&As from the AGM held on 09 July 2021
   
17 June 2021 Notice of Annual General Meeting held on 09 July 2021
  Proxy for the Annual General Meeting held on 09 July 2021
   
09 July 2020 Results of the Proxy votes for the AGM held on 09 July 2020
  Shareholders Q&As from the AGM held on 09 July 2020
   
18 June 2020 Notice of Annual General Meeting held on 09 July 2020
  Proxy for the Annual General Meeting held on 09 July 2020
   
17 May 2019 Notice of Annual General Meeting held on 11 June 2019
  Proxy for use at the Annual General Meeting held on 11 June 2019
   
11 June 2018 Notice of Annual General Meeting held on 4 July 2018
  Proxy for use at the Annual General Meeting held on 4 July 2018
  Proposed New Articles of Association
   
08 January 2018 Notice of General Meeting held on 25 January 2018
  Proxy for use at the General Meeting held on 25 January 2018
   
25 April 2017 Notice of Annual General Meeting held on 15 June 2017
  Proxy for use at the Annual General Meeting held on 15 June 2017
   
14 April 2016 Notice of Annual General Meeting held on 10 May 2016
   
29 May 2015 Notice of Annual General Meeting held on 11 August 2015
   
23 July 2014 Notice of General Meeting held on 04 August 2014
  Form of Proxy for General Meeting held on 04 August 2014
   
30 January 2014 Notice of Annual General Meeting held on 24 February 2014
  Form of Proxy for General Meeting held on 24 February 2014
   
31 November 2013 Notice of General Meeting held on 18 November 2013

UK City Code on Takeovers and Mergers

As an AIM traded UK registered company, OptiBiotix Health Plc is subject to the UK City Code on Takeovers and Mergers legislation.

Page last updated: 18 August 2025

Latest RNS News

Latest Video

Latest Podcast